Management of hepatocellular carcinoma

@article{Bruix2005ManagementOH,
  title={Management of hepatocellular carcinoma},
  author={Jordi Bruix and Morris Sherman},
  journal={Hepatology},
  year={2005},
  volume={42}
}
The incidence of hepatocellular carcinoma (HCC) has increased worldwide and is now the 5th most frequent cancer representing approximately 5% of all cancers worldwide. More than 500,000 new cases are diagnosed per year and it is the third cause of cancer-related death and the first cause of death in patients with cirrhosis [1]. The incidence of HCC has major geographical differences, but most patients diagnosed with HCC have underlying cirrhosis. The highest risk is observed in cirrhosis from… 
Surgical Management of HCC
TLDR
The incidence and mortality from HCC in the United Kingdom is also increasing, despite greater aware‐ ness for the need for surveillance in patients with cirrhosis, and improvements in and access to imaging.
Hepatitis B virus genotype and mutants: risk factors for hepatocellular carcinoma.
  • J. LlovetA. Lok
  • Medicine, Biology
    Journal of the National Cancer Institute
  • 2008
TLDR
One-third of cirrhotic patients will develop HCC during their lifetime, and in Western countries and in Japan, hepatitis C virus (HCV) infection is the most prevalent risk factor for HCC.
Risk of recurrence in hepatitis B-related hepatocellular carcinoma: impact of viral load in late recurrence.
  • Y. Hoshida
  • Medicine, Biology
    Journal of hepatology
  • 2009
Autoimmune Hepatitis, Cirrhosis, and Hepatocellular Carcinoma (HCC)
TLDR
The cost-effectiveness largely depends on the outcomes of treatment, and so studies like the Chinese program, which lacked access to OLT, are not necessarily relevant to other centers where transplantation is the first-line treatment for patients with cirrhosis and a small tumour.
Prevention of hepatitis C virus infection and liver cancer.
  • E. LimJ. Torresi
  • Medicine, Biology
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer
  • 2014
TLDR
It is imperative to provide antiviral therapy to infected individuals prior to the development of established cirrhosis in order to reduce the risk of subsequent HCC, as the successful eradication of HCV is associated with clinical and histological improvement as well as a greatly reduced risk ofsequent HCC development.
Is family history of liver cancer a risk factor for hepatocellular carcinoma?
Modern diagnosis of hepatocellular carcinoma: Utilization of liver biopsy and genomic markers.
  • J. Marrero
  • Medicine, Biology
    Journal of hepatology
  • 2009
Chronic hepatitis B and hepatocellular carcinoma.
Hepatocarcinoma: from pathogenic mechanisms to target therapy
TLDR
A diagnostic approach to HCC has been developed incorporating serology, cytohistology, and radiological characteristics, and a precise staging of the disease may help decide on prognosis as well as choice of therapy with the greatest survival potential.
...
...

References

SHOWING 1-10 OF 365 REFERENCES
Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death
TLDR
The incidence of HCC and mortality should be higher in patients with uncomplicated Child-Pugh A HCV related cirrhosis than previously stated, and prognostic factors of H CC and death are closely related age and symptoms of portal hypertension.
Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in Japan
TLDR
An analysis of the effect of interferon therapy on the incidence and prevention of hepatocellular carcinoma in patients with chronic hepatitis C who have undergone liver biopsy at one of eight participating institutions supported by the Japan Ministry of Health and Welfare.
Hepatocellular carcinoma in Austria: aetiological and clinical characteristics at presentation
TLDR
The dominant contribution of HCV infection and chronic alcohol abuse as the underlying aetiology is documented in this large single‐centre series of HCC.
Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome
TLDR
HCC in HIV-infected patients is mainly associated with underlying chronic hepatitis C and has a more aggressive clinical course, so preventative strategies (including the treatment of hepatitis C) should be implemented in the management of HIV/HCV-coinfected patients.
Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001.
TLDR
Hepatitis C virus coinfection dramatically promotes the development of HCC and of cirrhosis, and is especially associated with Cirrhosis in the highly active antiretroviral therapy era.
Hepatocellular carcinoma in Italian patients with cirrhosis.
TLDR
In the West, as in Asia, patients with cirrhosis of the liver are at substantial risk for hepatocellular carcinoma, with a yearly incidence rate of 3 percent, and the screening program did not appreciably increase the rate of detection of potentially curable tumors.
Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives.
TLDR
First-degree relatives of patients with HBV-related HCC appear to be at increased risk of HCC and should be considered in the formulation of H CC-screening programs.
Sero‐clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis
TLDR
It is demonstrated that hepatitis B viremia may persist, and adverse complications were not rare in HBsAg‐clearance patients, and all such patients should be closely monitored, which may allow for earlier detection of HCC.
Characteristics of hepatocellular carcinoma in Italy.
...
...